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Comparative Study in Two Institutions Between IVUS and Pressure Wire in the
Assessment of Intermediate Lesions
Jose M De la Torre Hernandez1, Ramon Lopez Palop2, Tamara Garcia Camarero1,
Pilar Carrillo2, Gonzalo Martin Gorria1, Araceli Frutos2, Blanca Arnaez1, Julian
Roldan2
1Hemodinamica, Hospital U. Marques de Valdecilla, Santander, Spain; 2Hospital U.
San Juan, Alicante, Spain
Background: The assessment of intermediate coronary lesions can be done with IVUS
or pressure-wire derived fractional flow reserve (FFR). Both have their advantages
and limitations. There are not randomized trials comparing these strategies. There are
small registries from the same center but subjected to important biases.
Methods: In two public institutions the strategy for intermediate lesion evaluation has
been different in previous years, in one was based in IVUS (IVUS Center) and in the
other was based in FFR (FFR Center). We have compared the outcome of patients with
intermediate lesions (40-60%) assessed in a 4 years period (2006-2009) in both centers.
The criteria for revascularization was FFR <0.75 and a minimum lumen area <4mm2
in vessels >3 mm and <3.5 mm2 in vessels 2.5-3 mm.
Results: In the FFR center 471 patients were included (545 lesions studied). After FFR
measurement, 364 (67%) lesions were left untreated in 321 patients. In the IVUS center
352 pts were included (429 lesions studied). After IVUS examination, 228 (53%)
lesions were left untreated in 182 pts (p=0.0001 vs FFR center). The clinical and
angiographic profile of both groups was well balanced without significant differences.
In the FFR-deferred group at 12 months there were 3 cardiac deaths (not lesion related),
none lesion related infarctions and 7 (1.9%) target lesions were treated in 7 (2.1%) pts.
In 8 pts revascularization was done in other lesions and in 3 pts over a restenotic lesion.
In the IVUS-deferred group at 12 months there were 2 cardiac deaths (not lesion
related), none lesion related infarctions and 2 (0.9%) target lesions were treated in 2
(1%) pts (p=0.5 vs FFR center). In 5 patients revascularization was done in new lesions
and in other 5 pts over a restenotic lesion.
Conclusion: The assessment of intermediate lesions with IVUS induce a higher degree
of revascularization (47% vs 33%). At one year follow up both strategies result safe
with a very low rate of lesion-related events, only a 1-2% of revascularizations.
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Background: Intravascular ultrasound (IVUS) is widely used as an endpoint in studies
aimed at reducing progression or regression of coronary artery disease. However, the
relationship between long-term clinical outcomes and serial atheroma changes by IVUS
remains unclear.
Methods: Serial volumetric IVUS examinations (baseline and 14 months) were
performed in 338 stable angina pectoris patients with native coronary artery lesions.
When these patients underwent percutaneous coronary intervention for culprit lesions,
IVUS was also performed in their non-culprit vessels (without angiographically
documented coronary stenosis [<50%]). We compared 4-year clinical outcomes,
including major adverse cardio- and cerebrovascular events (MACCE), and annual
progression rate of atherosclerosis, assessed by serial volumetric IVUS (mean lengths:
43mm).
Results: The 4-year cumulative rate of MACCE was 21.3%. Coronary events were
adjudicated to be related to culprit lesions in 10.4% of patients and to non-culprit
lesions in 8.9%. By adjusting for validated prognosticators, diabetes (baseline
HbA1c>7.5%), prior history of cardiovascular disease, high age (>70 years), 3-vessel
disease, and large annual atheroma progression (atheroma volume >15% / year) were
identified as poor predictors of MACCE, whereas Statin and ARB/ACE administration
were identified as good predictors. Additionally, patients with adverse events (n=62)
had larger annual atheroma progression than the rest of the population (23.8±18.7%
vs. 2.1±13.8%, P<0.001).
Conclusion: Atheroma volume changes, assessed by volumetric IVUS, seem to be a
reliable surrogate for future major adverse cardio- and cerebrovascular events in this
study cohort.
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Background: In patients (pts) with acute coronary syndromes (ACS), residual
atherosclerotic disease after successful percutaneous coronary intervention (PCI) may
predispose to future major adverse cardiovascular events (MACE).
Methods: In PROSPECT, following successful PCI of all clinically significant lesions
in pts with ACS, three-vessel gray-scale and radiofrequency-intravascular ultrasound
(IVUS) was performed. Analyzable images were available in 660 pts, followed for a
median of 3.4 years.
Results: Total plaque burden was 49.6 ± 4.2% in imaged segments. At least one lesion
with a plaque burden ≥70% (PB70) was found in 220 (33%) patients. History of PCI
(OR 1.79 [1.07, 2.99]) and angiographic three-vessel disease (1.77 [1.24, 2.52]) were
independent predictors of pts with PB70 lesions. IVUS findings and clinical outcomes
are shown in the Table. Among imaged nonculprit lesions, the proportion of PB70
lesions causing clinical events was significantly greater than non-PB70 lesions (8.7%
vs. 1.0%, p <0.0001).
Baseline Imaging and 3-Year Outcomes in Patients with and without PB70
Lesions
Conclusion: Following successful PCI of all angiographically significant lesions,
overall atherosclerotic burden is high and PB70 lesions are frequently present in the
proximal and mid-coronary tree. Pts with PB70 lesions have a greater disease burden
and are at increased risk for future MACE.
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Background: We investigated mechanisms and potential differences in stent expansion
among transplant patients vs. patients with native coronary artery atherosclerotic
disease (“controls”).
Methods: We compared pre and post-stent intravascular ultrasound in 12 transplant
patients (17 lesions) and 33 control patients (34 lesions) matched according to age
(60.1±9.2 years), diabetes mellitus, and lesion location. Planar and volumetric analysis
was conducted for every 1 mm at the lesion site as well as the first 5 mm proximal and
distal to the stent edge. Focal stent expansion was defined as minimum stent area
(MSA) divided by mean reference lumen area. Diffuse stent expansion was defined as
mean stent area divided by mean reference lumen area.
Results: Transplant patients had more plaque than “controls” pre-stenting, but similar
MSA and focal and diffuse stent expansion afterwards. The increase in mean lumen
area correlated with the increase in mean vessel area in both groups - transplant
(R=0.64, p=0.008) and controls (R=0.70, p<0.0001), but correlated inversely with
changes in mean plaque area only in the transplant group (R=0.55, p=0.027) – Fig 1.
There were no differences in calcification between the two groups and no axial plaque
distribution from the lesion into the reference segments in either group.
www.JACC.TCTAbstracts2011
B182 JACC Vol 58/20/Suppl B  |  November 7-11, 2011  |  TCT Abstracts/POSTER/Intravascular Imaging: IVUS, OCT, Spectroscopy, and Other
P
O
S
T
E
R
S
